UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in irritable bowel syndrome and how to avoid them

Robin Spiller

Summary

AI Generated

This material addresses common mistakes in the diagnosis and management of irritable bowel syndrome, a heterogeneous condition affecting 11% of the global population with varied bowel habit presentations.

  • IBS affects approximately 11% of the worldwide population, making it one of the most frequent gastroenterological diagnoses.
  • All IBS patients experience recurrent abdominal pain, but bowel habits vary: around one-third have predominantly diarrhoea (IBS-D), one-fifth have predominantly constipation (IBS-C), and half have a mixed pattern (IBS-M).
  • The author states that IBS has multiple causes and requires an individualized approach to management and treatment.
  • The material is intended to review frequent mistakes in IBS diagnosis and management, based on published data and clinical experience.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10
1.
Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology 2021; 160: 99-114 e113.
2.
Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology 2016; 150: 1393-1407.e1395.
3.
Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020; 5: 908-917.
4.
Spiller RC, Humes DJ, Campbell E, et al. The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment Pharmacol Ther 2010; 32: 811-820.
5.
Hasler WL and Schoenfeld P. Systematic review: Abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17: 997-1005.
6.
van Lanen AS, de Bree A and Greyling A. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. Eur J Nutr 2021; 60: 3505-3522.
7.
Staudacher HM, Rossi M, Kaminski T, et al. Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterol Motil 2022; 34: e14241.
8.
Hill LS, Reid F, Morgan JF, et al. SCOFF, the development of an eating disorder screening questionnaire. Int J Eat Disord 2010; 43: 344-351.
9.
Mari A, Hosadurg D, Martin L, et al. Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? Eur J Gastroenterol Hepatol 2019; 31: 178-182.
10.
Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013; 145: 320-328 e321-323.
11.
Suarez FL, Savaiano DA and Levitt MD. A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995; 333: 1-4.
12.
Yang J, Deng Y, Chu H, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013; 11: 262-268 e261.
13.
Khasawneh M, Shaikh FA, Ng CE, et al. Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterol Motil 2024; 36: e14756.
14.
Houghton LA and Whorwell PJ. Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders. Neurogastroenterol Motil 2005; 17: 500-511.
15.
Houghton LA, Lea R, Agrawal A, et al. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology 2006; 131: 1003-1010.
16.
Barba E, Burri E, Quiroga S, et al. Visible abdominal distension in functional gut disorders: Objective evaluation. Neurogastroenterol Motil 2023; 35: e14466.
17.
Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver 2015; 9: 332-339.
18.
Slattery SA, Niaz O, Aziz Q, et al. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther 2015; 42: 3-11.
19.
Ford AC, Bercik P, Morgan DG, et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013; 145: 1262-1270 e1261.
20.
Burgmann T, Clara I, Graff L, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome? Clin Gastroenterol Hepatol 2006; 4: 614-620.
21.
van Rheenen PF, Van de Vijver E and Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010; 341: c3369.
22.
Cabrera-Abreu JC, Davies P, Matek Z, et al. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child 2004; 89: 69-71.
23.
Tuteja AK, Biskupiak J, Stoddard GJ, et al. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010; 22: 424-430, e496.
24.
Drossman D and Szigethy E. The narcotic bowel syndrome: a recent update. Am J Gastroenterol Suppl 2014; 2: 22-30.
25.
Cash BD, Lacy BE, Schoenfeld PS, et al. Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea. Am J Gastroenterol 2017; 112: 365-374.
26.
Kennedy TM and Jones RH. Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population. Br J Surg 2000; 87: 1658-1663.
27.
Kirk G, Kennedy R, McKie L, et al. Preoperative symptoms of irritable bowel syndrome predict poor outcome after laparoscopic cholecystectomy. Surg Endosc 2011; 25: 3379-3384.
28.
Breuer NF, Jaekel S, Dommes P, et al. Fecal bile acid excretion pattern in cholecystectomized patients. Dig Dis Sci 1986; 31: 953-960.
29.
Longstreth GF and Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004; 126: 1665-1673.
30.
Alderson SL, Wright-Hughes A, Ford AC, et al. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care. Trials 2022; 23: 552.

Abstract

Around 11% of the worldwide population experience irritable bowel syndrome (IBS), making it one of the most frequent gastroenterological diagnoses.1 The symptoms of IBS include abdominal pain associated with unpredictable bowel habits and variable changes in the form and frequency of stool.2 While all patients with IBS suffer from recurrent bouts of abdominal pain, their bowel habits are varied: around one-third suffer predominantly with diarrhoea (IBS-D), one-fifth experience predominantly constipation (IBS-C) and half have an erratic mixed pattern of both diarrhoea and constipation (IBS-M).3 This very heterogeneous condition undoubtedly has multiple causes and an individualized approach to management and treatment is required. Here I discuss the mistakes most frequently made when diagnosing and managing IBS. The mistakes and discussion that follow are based, where possible, on published data and failing that on many years of my own clinical experience.

Topics

Neurogastroenterology & Motility Primary Care

Citation

Spiller R. Mistakes in irritable bowel syndrome and how to avoid them. UEG Education 2016: 16; 31–33.

Published

2024

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Episode 5: UEG Journal September Spotlight

Episode 5: UEG Journal September Spotlight

Djuna L. Cahen Djuna L. Cahen, Mohsan Subhani

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Marco Soncini Marco Soncini, Renato Cannizzaro, Carolina Tomba, Carlo Agostoni, Guido Manfredi, Elisabetta Buscarini, Pasquale Mansueto, Stefania Orlando, Francesca Ferretti, Irene Motta, Maria Domenica Cappellini, Emma Paulon, Vincenzo De francesco, Fabio Monica, Riccardo Marmo, Massimo Bellini, Gioacchino Leandro, Claudio Romano, Salvatore Oliva, Carlo Maria Girelli, Antonio Carroccio, Angelo Zullo, Lorenzo Norsa, Luca Elli

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend, Philip Newsome

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10
1.
Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology 2021; 160: 99-114 e113.
2.
Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology 2016; 150: 1393-1407.e1395.
3.
Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020; 5: 908-917.
4.
Spiller RC, Humes DJ, Campbell E, et al. The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment Pharmacol Ther 2010; 32: 811-820.
5.
Hasler WL and Schoenfeld P. Systematic review: Abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17: 997-1005.
6.
van Lanen AS, de Bree A and Greyling A. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. Eur J Nutr 2021; 60: 3505-3522.
7.
Staudacher HM, Rossi M, Kaminski T, et al. Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterol Motil 2022; 34: e14241.
8.
Hill LS, Reid F, Morgan JF, et al. SCOFF, the development of an eating disorder screening questionnaire. Int J Eat Disord 2010; 43: 344-351.
9.
Mari A, Hosadurg D, Martin L, et al. Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? Eur J Gastroenterol Hepatol 2019; 31: 178-182.
10.
Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013; 145: 320-328 e321-323.
11.
Suarez FL, Savaiano DA and Levitt MD. A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995; 333: 1-4.
12.
Yang J, Deng Y, Chu H, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013; 11: 262-268 e261.
13.
Khasawneh M, Shaikh FA, Ng CE, et al. Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterol Motil 2024; 36: e14756.
14.
Houghton LA and Whorwell PJ. Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders. Neurogastroenterol Motil 2005; 17: 500-511.
15.
Houghton LA, Lea R, Agrawal A, et al. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology 2006; 131: 1003-1010.
16.
Barba E, Burri E, Quiroga S, et al. Visible abdominal distension in functional gut disorders: Objective evaluation. Neurogastroenterol Motil 2023; 35: e14466.
17.
Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver 2015; 9: 332-339.
18.
Slattery SA, Niaz O, Aziz Q, et al. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther 2015; 42: 3-11.
19.
Ford AC, Bercik P, Morgan DG, et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013; 145: 1262-1270 e1261.
20.
Burgmann T, Clara I, Graff L, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome? Clin Gastroenterol Hepatol 2006; 4: 614-620.
21.
van Rheenen PF, Van de Vijver E and Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010; 341: c3369.
22.
Cabrera-Abreu JC, Davies P, Matek Z, et al. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child 2004; 89: 69-71.
23.
Tuteja AK, Biskupiak J, Stoddard GJ, et al. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010; 22: 424-430, e496.
24.
Drossman D and Szigethy E. The narcotic bowel syndrome: a recent update. Am J Gastroenterol Suppl 2014; 2: 22-30.
25.
Cash BD, Lacy BE, Schoenfeld PS, et al. Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea. Am J Gastroenterol 2017; 112: 365-374.
26.
Kennedy TM and Jones RH. Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population. Br J Surg 2000; 87: 1658-1663.
27.
Kirk G, Kennedy R, McKie L, et al. Preoperative symptoms of irritable bowel syndrome predict poor outcome after laparoscopic cholecystectomy. Surg Endosc 2011; 25: 3379-3384.
28.
Breuer NF, Jaekel S, Dommes P, et al. Fecal bile acid excretion pattern in cholecystectomized patients. Dig Dis Sci 1986; 31: 953-960.
29.
Longstreth GF and Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004; 126: 1665-1673.
30.
Alderson SL, Wright-Hughes A, Ford AC, et al. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care. Trials 2022; 23: 552.

Abstract

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a subclassification of steatotic liver disease (SLD), defined as the presence of excess triglyceride storage in the liver in conjunction with at least one cardiometabolic risk factor and no other discernible cause.1 Cirrhosis secondary to MASH is the most common cause of liver disease in the world and is the fastest-growing indication for liver transplantation, but it also has a >50% recurrence rate post-transplantation.

Topics

Hepatobiliary

Citation

Townsend SA and Newsome PN. Mistakes in nonalcoholic fatty liver disease and how to avoid them. UEG Education 2017; 17: 39–41.

Published

2024

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Episode 5: UEG Journal September Spotlight

Episode 5: UEG Journal September Spotlight

Djuna L. Cahen Djuna L. Cahen, Mohsan Subhani

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Marco Soncini Marco Soncini, Renato Cannizzaro, Carolina Tomba, Carlo Agostoni, Guido Manfredi, Elisabetta Buscarini, Pasquale Mansueto, Stefania Orlando, Francesca Ferretti, Irene Motta, Maria Domenica Cappellini, Emma Paulon, Vincenzo De francesco, Fabio Monica, Riccardo Marmo, Massimo Bellini, Gioacchino Leandro, Claudio Romano, Salvatore Oliva, Carlo Maria Girelli, Antonio Carroccio, Angelo Zullo, Lorenzo Norsa, Luca Elli

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Mario Dinis-Ribeiro, Pradeep Mundre

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Stomach & H. Pylori

Published

2025

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Episode 5: UEG Journal September Spotlight

Episode 5: UEG Journal September Spotlight

Djuna L. Cahen Djuna L. Cahen, Mohsan Subhani

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Marco Soncini Marco Soncini, Renato Cannizzaro, Carolina Tomba, Carlo Agostoni, Guido Manfredi, Elisabetta Buscarini, Pasquale Mansueto, Stefania Orlando, Francesca Ferretti, Irene Motta, Maria Domenica Cappellini, Emma Paulon, Vincenzo De francesco, Fabio Monica, Riccardo Marmo, Massimo Bellini, Gioacchino Leandro, Claudio Romano, Salvatore Oliva, Carlo Maria Girelli, Antonio Carroccio, Angelo Zullo, Lorenzo Norsa, Luca Elli

UEG Podcast Episode
Journal Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Episode 5: UEG Journal September Spotlight

Mohsan Subhani, Djuna L. Cahen

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Published

2025

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Episode 5: UEG Journal September Spotlight

Episode 5: UEG Journal September Spotlight

Djuna L. Cahen Djuna L. Cahen, Mohsan Subhani

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Marco Soncini Marco Soncini, Renato Cannizzaro, Carolina Tomba, Carlo Agostoni, Guido Manfredi, Elisabetta Buscarini, Pasquale Mansueto, Stefania Orlando, Francesca Ferretti, Irene Motta, Maria Domenica Cappellini, Emma Paulon, Vincenzo De francesco, Fabio Monica, Riccardo Marmo, Massimo Bellini, Gioacchino Leandro, Claudio Romano, Salvatore Oliva, Carlo Maria Girelli, Antonio Carroccio, Angelo Zullo, Lorenzo Norsa, Luca Elli

UEG Standards and Guidelines
Consensus
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Guideline

ABSTRACT

Introduction

Chronic nausea and vomiting are symptoms of a wide range of gastrointestinal and non-gastrointestinal conditions. Diagnosis can be challenging and requires a systematic and well-structured approach. If the initial investigation for structural, toxic and metabolic disorders is negative, digestive motility and gut-brain interaction disorders should be assessed. United European Gastroenterology (UEG) and the European Society for Neurogastroenterology and Motility (ESNM) identified the need for an updated, evidence-based clinical guideline for the management of chronic nausea and vomiting.

Methods

A multidisciplinary team of experts in the field, including European specialists and national societies, participated in the development of the guideline. Relevant questions were addressed through a literature review and statements were developed and voted on according to a Delphi process.

Results

Ninety-eight statements were identified and voted following the Delphi process. Overall agreement was high, although the grade of scientific evidence was low in many areas. Disagreement was more evident for some pharmacological treatment options. A diagnostic algorithm was developed, focussing on the differentiating features between gastrointestinal motility and gut-brain interaction disorders with predominant nausea and vomiting.

Conclusion

These guidelines provide an evidence-based framework for the evaluation and treatment of patients with chronic nausea and vomiting.

Publisher

European Society of Neurogastroenterology and Motility logo
European Society of Neurogastroenterology and Motility

Guideline

Consensus

Topics

Neurogastroenterology & Motility Paediatrics Primary Care Stomach & H. Pylori

Citation

United European Gastroenterol J.

Published

2025

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Episode 5: UEG Journal September Spotlight

Episode 5: UEG Journal September Spotlight

Djuna L. Cahen Djuna L. Cahen, Mohsan Subhani

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Marco Soncini Marco Soncini, Renato Cannizzaro, Carolina Tomba, Carlo Agostoni, Guido Manfredi, Elisabetta Buscarini, Pasquale Mansueto, Stefania Orlando, Francesca Ferretti, Irene Motta, Maria Domenica Cappellini, Emma Paulon, Vincenzo De francesco, Fabio Monica, Riccardo Marmo, Massimo Bellini, Gioacchino Leandro, Claudio Romano, Salvatore Oliva, Carlo Maria Girelli, Antonio Carroccio, Angelo Zullo, Lorenzo Norsa, Luca Elli

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord, Roos E. Pouw

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10
1.
Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology 2021; 160: 99-114 e113.
2.
Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology 2016; 150: 1393-1407.e1395.
3.
Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020; 5: 908-917.
4.
Spiller RC, Humes DJ, Campbell E, et al. The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment Pharmacol Ther 2010; 32: 811-820.
5.
Hasler WL and Schoenfeld P. Systematic review: Abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17: 997-1005.
6.
van Lanen AS, de Bree A and Greyling A. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. Eur J Nutr 2021; 60: 3505-3522.
7.
Staudacher HM, Rossi M, Kaminski T, et al. Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterol Motil 2022; 34: e14241.
8.
Hill LS, Reid F, Morgan JF, et al. SCOFF, the development of an eating disorder screening questionnaire. Int J Eat Disord 2010; 43: 344-351.
9.
Mari A, Hosadurg D, Martin L, et al. Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? Eur J Gastroenterol Hepatol 2019; 31: 178-182.
10.
Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013; 145: 320-328 e321-323.
11.
Suarez FL, Savaiano DA and Levitt MD. A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995; 333: 1-4.
12.
Yang J, Deng Y, Chu H, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013; 11: 262-268 e261.
13.
Khasawneh M, Shaikh FA, Ng CE, et al. Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterol Motil 2024; 36: e14756.
14.
Houghton LA and Whorwell PJ. Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders. Neurogastroenterol Motil 2005; 17: 500-511.
15.
Houghton LA, Lea R, Agrawal A, et al. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology 2006; 131: 1003-1010.
16.
Barba E, Burri E, Quiroga S, et al. Visible abdominal distension in functional gut disorders: Objective evaluation. Neurogastroenterol Motil 2023; 35: e14466.
17.
Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver 2015; 9: 332-339.
18.
Slattery SA, Niaz O, Aziz Q, et al. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther 2015; 42: 3-11.
19.
Ford AC, Bercik P, Morgan DG, et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013; 145: 1262-1270 e1261.
20.
Burgmann T, Clara I, Graff L, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome? Clin Gastroenterol Hepatol 2006; 4: 614-620.
21.
van Rheenen PF, Van de Vijver E and Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010; 341: c3369.
22.
Cabrera-Abreu JC, Davies P, Matek Z, et al. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child 2004; 89: 69-71.
23.
Tuteja AK, Biskupiak J, Stoddard GJ, et al. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010; 22: 424-430, e496.
24.
Drossman D and Szigethy E. The narcotic bowel syndrome: a recent update. Am J Gastroenterol Suppl 2014; 2: 22-30.
25.
Cash BD, Lacy BE, Schoenfeld PS, et al. Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea. Am J Gastroenterol 2017; 112: 365-374.
26.
Kennedy TM and Jones RH. Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population. Br J Surg 2000; 87: 1658-1663.
27.
Kirk G, Kennedy R, McKie L, et al. Preoperative symptoms of irritable bowel syndrome predict poor outcome after laparoscopic cholecystectomy. Surg Endosc 2011; 25: 3379-3384.
28.
Breuer NF, Jaekel S, Dommes P, et al. Fecal bile acid excretion pattern in cholecystectomized patients. Dig Dis Sci 1986; 31: 953-960.
29.
Longstreth GF and Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004; 126: 1665-1673.
30.
Alderson SL, Wright-Hughes A, Ford AC, et al. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care. Trials 2022; 23: 552.

Abstract

Proton pump inhibitors (PPIs), first introduced with omeprazole in 1988, revolutionized the treatment of gastric acid-related conditions like gastro-oesophageal reflux disease, gastroduodenal ulcers, and Helicobacter pylori infections. Despite their effectiveness, PPIs are often prescribed for conditions without a proven link to gastric acid, such as dyspepsia and upper abdominal discomfort. Long-term use of PPIs has raised safety concerns, including risks of vitamin and mineral malabsorption, pneumonia, gastrointestinal infections, and dementia. This Mistakes In article addresses nine common mistakes in PPI use and aims to clarify misconceptions about their use.

Topics

Digestive Oncology Oesophagus

Citation

Pouw R.E. and Bredenoord A.J. Mistakes in the use of PPIs and how to avoid them. UEG Education 2017; 17: 15–17.

Published

2024

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Episode 5: UEG Journal September Spotlight

Episode 5: UEG Journal September Spotlight

Djuna L. Cahen Djuna L. Cahen, Mohsan Subhani

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Marco Soncini Marco Soncini, Renato Cannizzaro, Carolina Tomba, Carlo Agostoni, Guido Manfredi, Elisabetta Buscarini, Pasquale Mansueto, Stefania Orlando, Francesca Ferretti, Irene Motta, Maria Domenica Cappellini, Emma Paulon, Vincenzo De francesco, Fabio Monica, Riccardo Marmo, Massimo Bellini, Gioacchino Leandro, Claudio Romano, Salvatore Oliva, Carlo Maria Girelli, Antonio Carroccio, Angelo Zullo, Lorenzo Norsa, Luca Elli

UEG Standards and Guidelines
Clinical Practice Guideline
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Luca Elli, Lorenzo Norsa, Angelo Zullo, Antonio Carroccio, Carlo Maria Girelli, Salvatore Oliva, Claudio Romano, Gioacchino Leandro, Massimo Bellini, Riccardo Marmo, Marco Soncini, Fabio Monica, Vincenzo De francesco, Emma Paulon, Maria Domenica Cappellini, Irene Motta, Francesca Ferretti, Stefania Orlando, Pasquale Mansueto, Elisabetta Buscarini, Guido Manfredi, Carlo Agostoni, Carolina Tomba, Renato Cannizzaro

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Guideline

Summary

Anaemia is a common pathologic condition, present in almost 5% of the adult population. Iron deficiency is the most common cause; other mechanisms can be involved, making anaemia a multi-factorial disorder in most cases. Anaemia being a frequent manifestation in the diseases of the gastrointestinal tract, patients are often referred to gastroenterologists. Furthermore, upper and lower endoscopy and enteroscopy are pivotal to the diagnostic roadmap of anaemia. In spite of its relevance in the daily clinical practice, there is a limited number of gastroenterological guidelines dedicated to the diagnosis of anaemia. For this reason, the Italian Association of Hospital Gastroenterologists and Endoscopists and the Italian Society of Paediatric Gastroenterology, Hepatology and Nutrition commissioned a panel of experts to prepare a specific guideline on anaemia and its diagnostic roadmap in the gastroenterological scenario. The panel also discussed about the potential involvement of gastroenterologists and endoscopists in the management of patients with anaemia, with particular attention to the correct use of investigations. The panel paid particular attention to practical issues with the aim to support gastroenterologists in their clinical practice when dealing with patients with anaemia.

Keywords: anaemia; celiac disease; endoscopy; H. pylori; inflammatory bowel disease; iron deficiency; small bowel

Guideline

Clinical Practice Guideline

Topics

Digestive Oncology Endoscopy IBD Paediatrics Primary Care Radiology & Imaging Small Intestine & Nutrition Stomach & H. Pylori

Citation

Dig Liver Dis. 2019 Apr;51(4):471-483

Published

2019

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Episode 5: UEG Journal September Spotlight

Episode 5: UEG Journal September Spotlight

Djuna L. Cahen Djuna L. Cahen, Mohsan Subhani

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

Marco Soncini Marco Soncini, Renato Cannizzaro, Carolina Tomba, Carlo Agostoni, Guido Manfredi, Elisabetta Buscarini, Pasquale Mansueto, Stefania Orlando, Francesca Ferretti, Irene Motta, Maria Domenica Cappellini, Emma Paulon, Vincenzo De francesco, Fabio Monica, Riccardo Marmo, Massimo Bellini, Gioacchino Leandro, Claudio Romano, Salvatore Oliva, Carlo Maria Girelli, Antonio Carroccio, Angelo Zullo, Lorenzo Norsa, Luca Elli

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.